Flagship Pioneering Special Opportunities Fund II, 10% Owner of Generate Biomedicines GENB, has filed 5 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $75M. The latest trade was on 03/02.

FI

FI

Flagship Pioneering Special Opportunities Fund II

10% Owner

Company

Generate Biomedicines GENB

First filing

23/02/27

Trades

28 trades

Buys / sales

5 / 0

12-month net buying

$75M

Last trade

03/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Generate BiomedicinesGENB	Open-market buy	03/02	03/02	4,687,500 sh3 trades	$16.00avg.	$75,000,000	No record
OT Omega Therapeutics	Open-market buy	23/02/27	23/02/27	3,323,310 sh2 trades	$5.78avg.	$19,208,731.8	No record